Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Dev Ind Pharm ; 46(5): 706-716, 2020 May.
Article in English | MEDLINE | ID: mdl-32266837

ABSTRACT

The aim of the present work was to develop a promising drug delivery system of oxiconazole nitrate-loaded solid lipid nanoparticles (SLNs) topical gel to enhance the drug effectiveness for the treatment of Tinea infection. SLNs were prepared by emulsification-solvent evaporation method. Particle size and entrapment efficiency of the prepared SLNs were investigated. An appropriate formulation was selected and examined for morphology and physicochemical characterization adopting Scanning electron microscope and Differential scanning colorimetry. In-vitro drug release was also investigated. The selected SLNs were loaded into 1% Carbopol 934 gel that was investigated for homogeneity, pH, grittiness, spreadability, viscosity and in vitro drug release. Clinical study for the developed gel system compared to the corresponding marketed product was conducted on 28 patients. The results revealed that the prepared oxiconazole nitrate SLNs had drug entrapment efficiency ranging from 41.34% to 75.07% and zeta potential lying between -13 and -50. Physicochemical characterization revealed a decrease in the drug crystallinity in the prepared SLNs. The gel formulation showed appropriate physical characteristics and sustained in-vitro drug release. Clinical study for the prepared oxiconazole nitrate SLNs gel showed significantly less side effects, better patient satisfaction and superior clinical improvement compared with the corresponding marketed product.


Subject(s)
Acrylic Resins/administration & dosage , Antifungal Agents/administration & dosage , Imidazoles/administration & dosage , Nanoparticles/administration & dosage , Skin Absorption/drug effects , Tinea/drug therapy , Acrylic Resins/chemical synthesis , Acrylic Resins/metabolism , Adult , Animals , Antifungal Agents/chemical synthesis , Antifungal Agents/metabolism , Drug Carriers/administration & dosage , Drug Carriers/chemical synthesis , Drug Carriers/metabolism , Drug Compounding/methods , Female , Gels , Humans , Imidazoles/chemical synthesis , Imidazoles/metabolism , Lipids , Male , Middle Aged , Nanoparticles/chemistry , Nanoparticles/metabolism , Organ Culture Techniques , Rats , Rats, Wistar , Skin Absorption/physiology , Tinea/metabolism , Tinea/pathology , Young Adult
2.
J Dermatolog Treat ; 27(5): 473-9, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27027929

ABSTRACT

The aim of this study is to evaluate four drug regimens for treatment of scabies as regard their efficacy, acceptability and cost effectiveness. Two hundred cases with ordinary scabies were randomized into four groups. First group received ivermectin 200 µg/kg body weight single oral dose, repeated after one week. The second received benzyl benzoate 20% cream. The third received permethrin 2.5%-5% lotion, whereas the fourth group received 5-10% sulfur ointment. Topical treatments were applied for five consecutive nights. Patients were followed up for two weeks for cure rate and adverse effects. At the end of the study, permethrin provided a significant efficacy of 88% and acceptability in 100% of cases, but had higher cost to treat one case (20.25 LE). Ivermectin provided efficacy and acceptability rates of 84% and 96%, respectively, and had a cheaper cost (9.5 LE). Benzyl benzoate provided 80% for both rates and was the cheapest drug. Sulfur ointment provided the least rates, and it was the most expensive. Treatment choice will depend on the age, the general condition of cases, patient compliance to topical treatment and his ability to stick to its roles, and the economic condition of the patient.


Subject(s)
Benzoates/therapeutic use , Insecticides/therapeutic use , Ivermectin/therapeutic use , Permethrin/therapeutic use , Scabies/drug therapy , Sulfur/therapeutic use , Adult , Benzoates/economics , Cost-Benefit Analysis , Female , Humans , Insecticides/economics , Ivermectin/economics , Male , Middle Aged , Patient Satisfaction , Permethrin/economics , Sulfur/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...